Clinical trial NCT04208724: Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based Organization
Official title: Implementation Studio, an Innovative, Structured Approach to Facilitate Rural Community-Based Organizations' Adaptation and Implementation of Evidence-Based Interventions
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Breast Carcinoma
Cervical Carcinoma
Colorectal Carcinoma
Malignant Solid Neoplasm
Lead sponsor: Fred Hutchinson Cancer Center
Sponsor class: OTHER
First posted: 2019-12-23
Enrollment: 35
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: HEALTH_SERVICES_RESEARCH

Brief summary: This pilot trial study uses a structural support program for adoption of cancer screening interventions at a rural community-based organization. Rural communities face unique barriers in implementation of evidence-based interventions due to a lack of infrastructure, community capacity, and expertise as academic and research centers are often clustered in urban areas. The support program may help a rural community-based organization select, adapt, and implement cancer prevention and control evidence-based interventions.

Detailed description: OUTLINE:

Community-based organizations participate in the support program, consisting of 2 half-day training workshops over 2 weeks, and 30-minute bi-weekly consultations in order to adapt and implement the cancer screening intervention for community members.

After completion of study, participants are followed up at 3 months.

Eligibility criteria: Inclusion Criteria:

* Objective II COMMUNITY-BASED ORGANIZATION: Located in the Yakima Valley of Washington State
* Objective II COMMUNITY-BASED ORGANIZATION: Serve community members who are 18 and older
* Objective II COMMUNITY-BASED ORGANIZATION: Willing to commit to the 6-month program
* Objective II PARTICIPANTS: Receiving services from the recruited community-based organization
* Objective III PARTICIPANTS: Not up-to-date for breast, cervical, and colorectal cancer screening according to current U.S. Preventive Services Tasks Force (USPSTF) guidelines. The current USPSTF recommendations for breast, cervical, and colorectal cancer are:

  * Breast Cancer Screening: Women ages 50-74 should be screened for breast cancer with mammography every 2 years.
  * Cervical Cancer Screening: Women ages 21-29 should be screened for cervical cancer every 3 years with cervical cancer cytology alone. For women ages 30-65, the USPSTF recommends screening every 3 years with cervical cytology alone, every 5 years or every 5 years with high risk human papillomavirus (hrHPV) testing in combination of cytology.
  * Colorectal Cancer Screening: Individuals ages 50-75 should be screened for colorectal cancer with guaiac-based fecal occult blood tests (gFOBT) or fecal immunochemical test (FIT) once a year, or colonoscopy every 10 years (USPSTF approves additional screening tests, but these are the most commonly used).
* Objective III PARTICIPANTS: If the community-based organization selects breast cancer screening, we will recruit women ages 50-74.
* Objective III PARTICIPANTS: If the community-based organization selects cervical cancer screening, we will recruit women ages 21-65.
* Objective III PARTICIPANTS: If the community-based organization selects colorectal cancer screening, we will recruit women and men ages 50-75.
* Objective III PARTICIPANTS: Average risk for breast, cervical, or colorectal cancer

Primary outcomes:
measure: Develop the structural program
timeFrame: 3 months
measure: Implementation Monitoring
timeFrame: 4 months
measure: Intention to get screened for cancer (type of cancer will be determined by the community-based organization) pre- and post-intervention
timeFrame: Up to 3 months
Secondary outcomes:
Other outcomes:
Locations:
city: Seattle
country: United States
facility: Fred Hutch/University of Washington Cancer Consortium
state: Washington
Study officials:
affiliation: Fred Hutch/University of Washington Cancer Consortium
name: Linda Ko
role: PRINCIPAL_INVESTIGATOR
References: